-
EP2903965
European procedure
Extract from the Register of European Patents
EP About this file: EP2903965
| EP2903965 - N-PROP-2-YNYL CARBOXAMIDE DERIVATIVES AND THEIR USE AS TRPA1 ANTAGONISTS [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 05.01.2018 Database last updated on 22.05.2024 | |
| Former | The patent has been granted Status updated on 27.01.2017 | ||
| Former | Grant of patent is intended Status updated on 18.01.2017 | Most recent event Tooltip | 05.01.2018 | No opposition filed within time limit | published on 07.02.2018 [2018/06] | Applicant(s) | For all designated states Orion Corporation Orionintie 1 02200 Espoo / FI | [2015/33] | Inventor(s) | 01 /
ARVELA, Riina Rauhankatu 32 as. 8 FI-20100 Turku / FI | 02 /
HEIKKINEN, Terhi Jalaskuja 7 B FI-21420 Lieto / FI | 03 /
HOLM, Patrik Nilsbynkaari 77 FI-21630 Lielahti / FI | 04 /
PRUSIS, Peteris Ruotumiehenkatu 7 B 35 FI-20360 Turku / FI | 05 /
ROSLUND, Mattias Vähä Hämeenkatu 2 C 85 FI-20500 Turku / FI | 06 /
SALO, Harri Puolikontie 6 C FI-20300 Turku / FI | [2015/33] | Representative(s) | J A Kemp LLP 80 Turnmill Street London EC1M 5QU / GB | [N/P] |
| Former [2015/33] | Sexton, Jane Helen J A Kemp 14 South Square Gray's Inn London WC1R 5JJ / GB | Application number, filing date | 13779617.3 | 30.09.2013 | [2015/33] | WO2013FI00034 | Priority number, date | US201261708330P | 01.10.2012 Original published format: US 201261708330 P | [2015/33] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2014053694 | Date: | 10.04.2014 | Language: | EN | [2014/15] | Type: | A1 Application with search report | No.: | EP2903965 | Date: | 12.08.2015 | Language: | EN | The application published by WIPO in one of the EPO official languages on 10.04.2014 takes the place of the publication of the European patent application. | [2015/33] | Type: | B1 Patent specification | No.: | EP2903965 | Date: | 01.03.2017 | Language: | EN | [2017/09] | Search report(s) | International search report - published on: | EP | 10.04.2014 | Classification | IPC: | C07C237/30, C07C237/44, C07C255/58, C07C323/63, C07D209/08, C07D213/81, C07D213/82, C07D215/48, C07D239/42, C07D317/58, C07D319/18, C07D333/38, C07D405/12, C07D417/12, A61K31/166 | [2015/33] | CPC: |
C07D213/82 (EP,US);
A61K31/166 (EP,US);
A61K31/277 (EP,US);
A61K31/357 (EP,US);
A61K31/4439 (EP,US);
A61K31/444 (EP,US);
A61K31/455 (EP,US);
A61K31/472 (EP,US);
A61K31/505 (EP,US);
A61K31/5377 (EP,US);
A61P1/00 (EP);
A61P11/00 (EP);
A61P11/06 (EP);
A61P11/14 (EP);
A61P19/02 (EP);
A61P25/00 (EP);
A61P25/04 (EP);
A61P25/06 (EP);
A61P29/00 (EP);
A61P3/10 (EP);
A61P43/00 (EP);
A61P5/48 (EP);
C07C237/30 (EP,US);
C07C237/44 (EP,US);
C07C255/58 (EP,US);
C07C255/60 (US);
C07C323/63 (EP,US);
C07D209/08 (EP,US);
C07D213/81 (EP,US);
C07D215/48 (EP,US);
C07D217/02 (EP,US);
C07D239/42 (EP,US);
C07D317/58 (EP,US);
C07D319/18 (EP,US);
C07D333/38 (EP,US);
C07D401/12 (EP,US);
C07D405/12 (EP,US);
C07D417/12 (EP,US);
C07C2601/02 (EP,US);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2015/33] | Extension states | BA | 25.03.2015 | ME | 25.03.2015 | Title | German: | N-PROP-2-YNYL CARBOXAMID- DERIVATIVE UND IHRE VERWENDUNG ALS TRPA1 ANTAGONISTEN | [2016/40] | English: | N-PROP-2-YNYL CARBOXAMIDE DERIVATIVES AND THEIR USE AS TRPA1 ANTAGONISTS | [2015/33] | French: | DÉRIVÉS DE N-PROP-2-YNYL CARBOXAMIDE ET LEUR UTILISATION EN TANT QU'ANTAGONISTES DE TRPA1 | [2016/40] |
| Former [2015/33] | N-PROP-2-YNYL-CARBOXAMIDDERIVATE UND DEREN VERWENDUNG ALS TRPA1-ANTAGONISTEN | ||
| Former [2015/33] | DÉRIVÉS DE N-PROP-2-YNYL-CARBOXAMIDE ET LEUR UTILISATION À TITRE D'ANTAGONISTES DE TRPA1 | Entry into regional phase | 25.03.2015 | National basic fee paid | 25.03.2015 | Designation fee(s) paid | 25.03.2015 | Examination fee paid | Examination procedure | 25.03.2015 | Examination requested [2015/33] | 20.11.2015 | Amendment by applicant (claims and/or description) | 19.04.2016 | Despatch of a communication from the examining division (Time limit: M04) | 08.07.2016 | Reply to a communication from the examining division | 22.09.2016 | Communication of intention to grant the patent | 17.01.2017 | Fee for grant paid | 17.01.2017 | Fee for publishing/printing paid | 17.01.2017 | Receipt of the translation of the claim(s) | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 19.04.2016 | Opposition(s) | 04.12.2017 | No opposition filed within time limit [2018/06] | Fees paid | Renewal fee | 11.09.2015 | Renewal fee patent year 03 | 13.09.2016 | Renewal fee patent year 04 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [A] - VALLIN, KARL S. A. ET AL, "N-1-Alkyl-2-oxo-2-aryl amides as novel antagonists of the TRPA1 receptor", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, CODEN: BMCLE8; ISSN: 0960-894X, (20120901), vol. 22, no. 17, pages 5485 - 5492, XP002716178 [A] 1-19 * the whole document * DOI: http://dx.doi.org/10.1016/j.bmcl.2012.07.032 |